Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus ropivacaine TAP block after laparoscopic colorectal surgery
ChiCTR2400082663Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Liposomal bupivacaine group with Ropivacaine group (2 arms). Primary endpoint: Exercise VAS pain score within 72 hours postoperatively. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400082663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082663.